Laurence Flint

Statistics

Publications

Citations

1.2K

H-Index

Active since

2011

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Laurence Flint is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacy, inflammatory disease pharmacotherapy, and inflammation.

Publications per year

2011–2013

Publications

Combination Therapy With Infliximab and Azathioprine Is Superior to Monotherapy With Either Agent in Ulcerative Colitis

Remo Panaccione, Subrata Ghosh, Stephen Middleton et al. · Gastroenterology · 2013 · 961 citations

Pharmacy, Immunology, Pharmacotherapy +12

Infliximab, Azathioprine, or Infliximab + Azathioprine for Treatment of Moderate to Severe Ulcerative Colitis: The UC Success Trial

Remo Panccione, Subrata Ghosh, Stephen Middleton et al. · Gastroenterology · 2011 · 120 citations

Pharmacy, Immunology, Pharmacotherapy +14

Efficacy and safety of infliximab as continuous or intermittent therapy in patients with moderate-to-severe plaque psoriasis: results of a randomized, long-term extension trial (RESTORE2)

Kristian Reich, Gottfried Wozel, Hong Zheng et al. · British Journal of Dermatology · 2013 · 110 citations

Pharmacy, Clinical Sciences, Pharmacotherapy +14

1–3 of 3